Skip to main content

ARTV

Stock

Performance overview

ARTV Price
Price Chart

Forward-looking statistics

Beta
0.22
Risk
98.02%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Company info

Sector
Industry
Website
Employees
Market cap

Fundamentals

Enterprise value-$115.2M
Revenue$251.0K
Revenue per employee
Profit margin0.00%
Debt to equity8.29

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$6.04
Dividend per share
Revenue per share$0.02
Avg trading volume (30 day)$698K
Avg trading volume (10 day)$1M
Put-call ratio

Macro factor sensitivity

Growth
Credit
Liquidity
Inflation
Commodities
Interest Rates

Valuation

Dividend yield0.00%
PEG Ratio-0.47
Price to sales156.27
P/E Ratio-0.47
Enterprise Value to Revenue-458.88
Price to book0.23

Upcoming events

Next earnings dayAugust 30, 2024
Next dividend day
Ex. dividend day

News

Artiva Biotherapeutics' Investigational Scalable Cell Therapies For Autoimmune Disorders, Analyst Initiate With Bullish Pitch

In July, Artiva Biotherapeutics, Inc. ARTV priced its upsized initial public offering of 13.92 million shares at $12.00 per share, with gross proceeds of approximately $167.0 million.

Benzinga (August 13, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free